Stock Events

Stock Events

BeyondSpring 

$1.5900
24
-$0.01-0.63% Wednesday 19:52

Statistics

Day High
1.648
Day Low
1.5701
52W High
3.36
52W Low
1.175
Volume
14,129
Avg. Volume
-
Mkt Cap
64.13M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4SepExpected
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Next
-0.05
0
0.06
0.11
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-22.25MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BYSI. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap294.03B
Merck & Co., Inc. is a global healthcare company that develops medications in oncology, among other areas, directly competing with BeyondSpring's cancer treatment pipeline.
Bristol-Myers Squibb
BMY
Mkt Cap116.66B
Bristol-Myers Squibb operates in the biopharmaceutical industry focusing on cancer treatments, making it a direct competitor to BeyondSpring's oncology-focused therapies.
Pfizer
PFE
Mkt Cap149.38B
Pfizer Inc. is involved in the discovery, development, and manufacture of healthcare products including cancer drugs, competing with BeyondSpring's offerings.
AMGEN
AMGN
Mkt Cap191.7B
Amgen Inc. focuses on human therapeutics, including oncology/hematology, which competes with BeyondSpring's cancer treatment developments.
Gilead Sciences
GILD
Mkt Cap155.93B
Gilead Sciences, Inc. is a biopharmaceutical company that develops and markets therapies in areas including oncology, competing with BeyondSpring's cancer drugs.
Astrazeneca
AZN
Mkt Cap277.22B
AstraZeneca PLC is a multinational pharmaceutical and biopharmaceutical company with a strong emphasis on oncology, making it a competitor to BeyondSpring.
Novartis
NVS
Mkt Cap292.07B
Novartis AG focuses on patented medicines across multiple segments, including oncology, directly competing with BeyondSpring's cancer therapies.
Roche
RHHBY
Mkt Cap332.67B
Roche Holding AG specializes in pharmaceuticals and diagnostics. Its strong focus on oncology research and treatments makes it a competitor to BeyondSpring.
Johnson & Johnson
JNJ
Mkt Cap579.83B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, with its pharmaceutical segment competing in oncology.
Regeneron Pharmaceuticals
REGN
Mkt Cap64.18B
Regeneron Pharmaceuticals, Inc. is known for its innovation in biotechnology, including oncology, competing with BeyondSpring's research and drug development.

About

BeyondSpring Inc. is a clinical-stage biopharmaceutical company focused on developing novel cancer treatments. Its flagship product is Plinabulin, a selective immune-modulating and microtubule-binding agent. Plinabulin has successfully advanced through Phase III clinical trials for two distinct applications: the prevention of chemotherapy-induced neutropenia, and the treatment of advanced non-small cell lung cancer. The company is also exploring Plinabulin's efficacy in combination with various immuno-oncology drugs; specifically, alongside nivolumab (a PD-1 antibody) for NSCLC, and with nivolumab and ipilimumab (a CTLA-4 antibody) for small cell lung cancer (SCLC). Furthermore, it is being investigated in conjunction with PD-1 or PD-L1 antibodies and radiation to address a range of cancers. Beyond its lead asset, BeyondSpring's pipeline includes three preclinical-stage small molecule immune agents and a proprietary drug development platform. The company, founded in 2010, maintains its headquarters in New York, New York.
Show more...
CEO
Dr. Lan Huang Ph.D.
Employees
40
Country
United States
ISIN
KYG108301006

Listings

XNAS
US
BYSI
BOATS
BOATS
BYSI.BOATS

0 Comments

Share your thoughts

FAQ

What is BeyondSpring stock price today?▼
The current price of BYSI is $1.59 USD — it has decreased by -0.63% in the past 24 hours. Watch BeyondSpring stock price performance more closely on the chart.
What is BeyondSpring stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange BeyondSpring stocks are traded under the ticker BYSI.
Is BeyondSpring stock price growing?▼
BYSI stock has fallen by -3.64% compared to the previous week, the month change is a +13.98% rise, over the last year BeyondSpring has showed a -48.87% decrease.
What is BeyondSpring market cap?▼
Today BeyondSpring has the market capitalization of 64.13M
When is the next BeyondSpring earnings date?▼
BeyondSpring is going to release the next earnings report on September 04, 2026.
What were BeyondSpring earnings last quarter?▼
BYSI earnings for the last quarter are -0.05 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is BeyondSpring revenue for the last year?▼
BeyondSpring revenue for the last year amounts to 0 USD.
What is BeyondSpring net income for the last year?▼
BYSI net income for the last year is -22.25M USD.
How many employees does BeyondSpring have?▼
As of June 18, 2026, the company has 40 employees.
In which sector is BeyondSpring located?▼
BeyondSpring operates in the Health & Wellness sector.
When did BeyondSpring complete a stock split?▼
BeyondSpring has not had any recent stock splits.
Where is BeyondSpring headquartered?▼
BeyondSpring is headquartered in Florham Park, United States.